PMC:7111504 / 12684-13141 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"192","span":{"begin":208,"end":211},"obj":"Gene"},{"id":"193","span":{"begin":283,"end":288},"obj":"Gene"},{"id":"194","span":{"begin":428,"end":431},"obj":"Gene"},{"id":"195","span":{"begin":213,"end":216},"obj":"Gene"},{"id":"196","span":{"begin":439,"end":448},"obj":"Species"},{"id":"197","span":{"begin":83,"end":88},"obj":"Disease"}],"attributes":[{"id":"A192","pred":"tao:has_database_id","subj":"192","obj":"Gene:925"},{"id":"A193","pred":"tao:has_database_id","subj":"193","obj":"Gene:3105"},{"id":"A194","pred":"tao:has_database_id","subj":"194","obj":"Gene:6962"},{"id":"A195","pred":"tao:has_database_id","subj":"195","obj":"Gene:6962"},{"id":"A196","pred":"tao:has_database_id","subj":"196","obj":"Tax:2697049"},{"id":"A197","pred":"tao:has_database_id","subj":"197","obj":"MESH:D009369"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"T cell cross-reactivity has been instrumental for the T cell immunity against both tumor antigens and external pathogens. In that regard, a number of T cells have been extensively characterized including 1G4 CD8+ TCR, which is known to recognize the ‘SLLMWITQC’ peptide presented by HLA-A*02:01. We therefore set out to leverage the data from a recently published study 7 and exploit the possibility of cross reactivity of this TCR to any 2019-nCoV peptide."}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T153","span":{"begin":0,"end":6},"obj":"CL:0000084"},{"id":"T154","span":{"begin":54,"end":60},"obj":"CL:0000084"},{"id":"T155","span":{"begin":89,"end":97},"obj":"CHEBI:59132;CHEBI:59132"},{"id":"T156","span":{"begin":150,"end":157},"obj":"CL:0000084"},{"id":"T157","span":{"begin":283,"end":288},"obj":"PR:000002009"},{"id":"T158","span":{"begin":439,"end":448},"obj":"SP_7"},{"id":"T69209","span":{"begin":0,"end":6},"obj":"CL:0000084"},{"id":"T36975","span":{"begin":54,"end":60},"obj":"CL:0000084"},{"id":"T33303","span":{"begin":89,"end":97},"obj":"CHEBI:59132;CHEBI:59132"},{"id":"T36223","span":{"begin":150,"end":157},"obj":"CL:0000084"},{"id":"T80986","span":{"begin":283,"end":288},"obj":"PR:000002009"},{"id":"T35114","span":{"begin":439,"end":448},"obj":"SP_7"}],"text":"T cell cross-reactivity has been instrumental for the T cell immunity against both tumor antigens and external pathogens. In that regard, a number of T cells have been extensively characterized including 1G4 CD8+ TCR, which is known to recognize the ‘SLLMWITQC’ peptide presented by HLA-A*02:01. We therefore set out to leverage the data from a recently published study 7 and exploit the possibility of cross reactivity of this TCR to any 2019-nCoV peptide."}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T79","span":{"begin":2,"end":6},"obj":"Body_part"},{"id":"T80","span":{"begin":56,"end":60},"obj":"Body_part"},{"id":"T81","span":{"begin":152,"end":157},"obj":"Body_part"},{"id":"T82","span":{"begin":283,"end":286},"obj":"Body_part"}],"attributes":[{"id":"A79","pred":"fma_id","subj":"T79","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A80","pred":"fma_id","subj":"T80","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A81","pred":"fma_id","subj":"T81","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A82","pred":"fma_id","subj":"T82","obj":"http://purl.org/sig/ont/fma/fma84795"}],"text":"T cell cross-reactivity has been instrumental for the T cell immunity against both tumor antigens and external pathogens. In that regard, a number of T cells have been extensively characterized including 1G4 CD8+ TCR, which is known to recognize the ‘SLLMWITQC’ peptide presented by HLA-A*02:01. We therefore set out to leverage the data from a recently published study 7 and exploit the possibility of cross reactivity of this TCR to any 2019-nCoV peptide."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T19","span":{"begin":83,"end":88},"obj":"Disease"}],"attributes":[{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0005070"}],"text":"T cell cross-reactivity has been instrumental for the T cell immunity against both tumor antigens and external pathogens. In that regard, a number of T cells have been extensively characterized including 1G4 CD8+ TCR, which is known to recognize the ‘SLLMWITQC’ peptide presented by HLA-A*02:01. We therefore set out to leverage the data from a recently published study 7 and exploit the possibility of cross reactivity of this TCR to any 2019-nCoV peptide."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T171","span":{"begin":0,"end":6},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T172","span":{"begin":24,"end":27},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T173","span":{"begin":33,"end":45},"obj":"http://purl.obolibrary.org/obo/OBI_0000968"},{"id":"T174","span":{"begin":54,"end":60},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T175","span":{"begin":138,"end":139},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T176","span":{"begin":150,"end":157},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T177","span":{"begin":208,"end":211},"obj":"http://purl.obolibrary.org/obo/CLO_0053438"},{"id":"T178","span":{"begin":262,"end":269},"obj":"http://purl.obolibrary.org/obo/PR_000018263"},{"id":"T179","span":{"begin":287,"end":288},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T180","span":{"begin":343,"end":344},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T181","span":{"begin":449,"end":456},"obj":"http://purl.obolibrary.org/obo/PR_000018263"}],"text":"T cell cross-reactivity has been instrumental for the T cell immunity against both tumor antigens and external pathogens. In that regard, a number of T cells have been extensively characterized including 1G4 CD8+ TCR, which is known to recognize the ‘SLLMWITQC’ peptide presented by HLA-A*02:01. We therefore set out to leverage the data from a recently published study 7 and exploit the possibility of cross reactivity of this TCR to any 2019-nCoV peptide."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T88","span":{"begin":89,"end":97},"obj":"Chemical"},{"id":"T89","span":{"begin":262,"end":269},"obj":"Chemical"},{"id":"T90","span":{"begin":449,"end":456},"obj":"Chemical"}],"attributes":[{"id":"A88","pred":"chebi_id","subj":"T88","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"},{"id":"A89","pred":"chebi_id","subj":"T89","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"},{"id":"A90","pred":"chebi_id","subj":"T90","obj":"http://purl.obolibrary.org/obo/CHEBI_16670"}],"text":"T cell cross-reactivity has been instrumental for the T cell immunity against both tumor antigens and external pathogens. In that regard, a number of T cells have been extensively characterized including 1G4 CD8+ TCR, which is known to recognize the ‘SLLMWITQC’ peptide presented by HLA-A*02:01. We therefore set out to leverage the data from a recently published study 7 and exploit the possibility of cross reactivity of this TCR to any 2019-nCoV peptide."}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":83,"end":88},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"T cell cross-reactivity has been instrumental for the T cell immunity against both tumor antigens and external pathogens. In that regard, a number of T cells have been extensively characterized including 1G4 CD8+ TCR, which is known to recognize the ‘SLLMWITQC’ peptide presented by HLA-A*02:01. We therefore set out to leverage the data from a recently published study 7 and exploit the possibility of cross reactivity of this TCR to any 2019-nCoV peptide."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T146","span":{"begin":0,"end":121},"obj":"Sentence"},{"id":"T147","span":{"begin":122,"end":295},"obj":"Sentence"},{"id":"T148","span":{"begin":296,"end":457},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"T cell cross-reactivity has been instrumental for the T cell immunity against both tumor antigens and external pathogens. In that regard, a number of T cells have been extensively characterized including 1G4 CD8+ TCR, which is known to recognize the ‘SLLMWITQC’ peptide presented by HLA-A*02:01. We therefore set out to leverage the data from a recently published study 7 and exploit the possibility of cross reactivity of this TCR to any 2019-nCoV peptide."}

    MyTest

    {"project":"MyTest","denotations":[{"id":"32269766-31695703-30420973","span":{"begin":370,"end":372},"obj":"31695703"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"T cell cross-reactivity has been instrumental for the T cell immunity against both tumor antigens and external pathogens. In that regard, a number of T cells have been extensively characterized including 1G4 CD8+ TCR, which is known to recognize the ‘SLLMWITQC’ peptide presented by HLA-A*02:01. We therefore set out to leverage the data from a recently published study 7 and exploit the possibility of cross reactivity of this TCR to any 2019-nCoV peptide."}

    2_test

    {"project":"2_test","denotations":[{"id":"32269766-31695703-30420973","span":{"begin":370,"end":371},"obj":"31695703"}],"text":"T cell cross-reactivity has been instrumental for the T cell immunity against both tumor antigens and external pathogens. In that regard, a number of T cells have been extensively characterized including 1G4 CD8+ TCR, which is known to recognize the ‘SLLMWITQC’ peptide presented by HLA-A*02:01. We therefore set out to leverage the data from a recently published study 7 and exploit the possibility of cross reactivity of this TCR to any 2019-nCoV peptide."}